AIHC
Index Performance
+1.48%
AIHC
+1.44%
IBB
Overview
Description
The Intelligent Healthcare Select strategy (AIHC) uses OpenAI's GPT, Google's Gemini, and Anthropic's Claude to build a custom weighted portfolio of US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings31
What's inside?
Holdings
All holdings as of May 17, 2024
CSV download
| IDEXX Laboratories, Inc. (IDXX) | 3.42% | $44.88B | 7.10% | 61.60% | 12.35 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.41% | $114.89B | 14.21% | 87.25% | 9.80 |
| Intuitive Surgical, Inc. (ISRG) | 3.41% | $141.46B | 11.46% | 65.87% | 19.01 |
| AbbVie, Inc. (ABBV) | 3.39% | $293.88B | 0.70% | 66.84% | 6.96 |
| Stryker Corp. (SYK) | 3.39% | $127.50B | 9.73% | 60.92% | 7.10 |
| Edwards Lifesciences Corp. (EW) | 3.39% | $53.72B | 9.50% | 75.72% | 9.24 |
| Zoetis, Inc. (ZTS) | 3.39% | $79.42B | 9.50% | 68.95% | 9.44 |
| Neurocrine Biosciences, Inc. (NBIX) | 3.37% | $14.32B | 22.57% | 97.52% | 6.87 |
| Danaher Corp. (DHR) | 3.37% | $196.87B | -19.13% | 60.16% | 7.59 |
| Henry Schein, Inc. (HSIC) | 3.37% | $9.55B | 3.66% | 29.98% | 1.11 |
| Elevance Health, Inc. (ELV) | 3.36% | $127.30B | 0.96% | N/A | 0.86 |
| Johnson & Johnson (JNJ) | 3.35% | $372.17B | -13.55% | 68.78% | 4.37 |
| UnitedHealth Group, Inc. (UNH) | 3.35% | $482.86B | 8.56% | N/A | 1.42 |
| Merck & Co., Inc. (MRK) | 3.35% | $332.28B | 8.38% | 75.11% | 5.96 |
| Medtronic Plc (MDT) | 3.35% | $114.09B | 4.68% | 60.33% | 4.09 |
| Mettler-Toledo International, Inc. (MTD) | 3.34% | $32.52B | -0.30% | 57.23% | 8.11 |
| ResMed, Inc. (RMD) | 3.33% | $32.11B | 7.17% | 56.94% | 6.57 |
| Grifols SA (GRF) | 3.32% | $6.42B | 8.71% | 35.24% | 3.37 |
| Pfizer Inc. (PFE) | 3.31% | $162.29B | -18.61% | 70.56% | 3.92 |
| Eli Lilly & Co. (LLY) | 3.31% | $731.81B | 25.98% | 80.91% | 20.23 |
| HCA Healthcare, Inc. (HCA) | 3.31% | $84.56B | 11.21% | 14.76% | 1.99 |
| Amgen, Inc. (AMGN) | 3.30% | $167.62B | 22.19% | 56.73% | 7.04 |
| Abbott Laboratories (ABT) | 3.29% | $181.08B | 2.23% | 50.40% | 5.13 |
| Thermo Fisher Scientific, Inc. (TMO) | 3.29% | $227.24B | -3.41% | 40.76% | 5.92 |
| Cencora, Inc. (ABC) | 3.29% | $44.30B | 7.81% | 3.30% | 0.19 |
| Laboratory Corp. of America Holdings (LH) | 3.27% | $17.75B | -15.92% | 26.36% | 1.98 |
| ACADIA Pharmaceuticals, Inc. (ACAD) | 3.27% | $2.44B | 73.75% | 88.85% | 3.28 |
| Universal Health Services, Inc. (UHS) | 3.26% | $10.60B | 10.85% | 10.11% | 1.21 |
| Bristol Myers Squibb Co. (BMY) | 3.23% | $89.25B | 4.66% | 55.54% | 3.46 |
| Align Technology, Inc. (ALGN) | 3.21% | $20.44B | 5.76% | 70.51% | 6.11 |
| GE Healthcare Technologies, Inc. (GEHC) | <0.01% | $37.37B | -1.21% | 41.23% | 2.51 |
Market data by FactSet